12:00 AM
Jul 31, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Colazal balsalazide regulatory update

The FDA granted marketing approval for Colazal, a prodrug of 5-aminosalicylic acid (5-ASA), to...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >